Pfizer Uruguay and BioNTech SE said in a release that Uruguay will be receiving 2,700,00 doses of the BNT162b2 vaccine, based on ARNm, against the SARS-CoV-2 and delivery will take place “progressively during 2021”
BioNTech, the co-producer of Pfizer’s Covid-19 vaccine, boosted the 2021 delivery target for their product to 2 billion doses, up from 1,3 billion previously as they bring new production lines on stream and as more doses can be extracted per vial.
A panel of outside advisers to the US Food and Drug Administration on Thursday (Dec 10) voted overwhelmingly to endorse emergency use of Pfizer Inc's coronavirus vaccine, paving the way for the agency to authorize the shot for a nation that has lost more than 285,000 lives to Covid-19.
US drugmaker Pfizer and its German partner BioNTech said on Wednesday that documents related to the development of their Covid-19 vaccine had been “unlawfully accessed” in a cyberattack on Europe’s medicines regulator. The European Medicines Agency, EMA, which assesses medicines and vaccines for the EU said hours earlier it had been targeted in a cyber attack.
Pfizer plans to ship 800,000 doses to Britain in the coming days from its production plant in Puurs in Belgium. Britain on Wednesday gave emergency use authorization for the Pfizer vaccine, becoming the first Western country to pave the way for mass inoculations against a disease that has killed more than 1.4 million people worldwide.
The United Kingdom steps forward the United States and Europe and became the first Western country to approve a Covid-19 vaccine for general use as it announced on Wednesday a rollout of Pfizer-BioNTech’s drug from next week.
The U.S. Food and Drug Administration's outside advisers will meet on Dec. 10 to discuss whether to authorize the COVID-19 vaccine developed by Pfizer Inc and German partner BioNTech for emergency use, the agency said on Friday.
The United States' top infectious disease official said that two coronavirus vaccines being tested were solid, and that the speed at which they were developed has not compromised safety or integrity.
Europe's leading stock exchanges traded steadily on Tuesday after Monday's euphoria when they were boosted by the announcement of the Pfizer-BioNTech vaccine, which is 90% effective thanks to a new technology called 'Messenger Ribonucleic Acid' or messenger RNA.